60 Capsules Nicotinamide Single Nucleotide Capsules

60 Capsules Nicotinamide Single Nucleotide Capsules is a product from Vivalo, categorized under Longevity & cellular health in the Supplements vertical. It is scored on the Vyvata Scoring Framework — an independent 6-dimension rubric applied uniformly to every product Vyvata lists.

42/100 overall — Rejected tier (0–49 band). Per-dimension breakdown: Safety 60, Evidence 45, Manufacturing 45, Sustainability 45, Formulation 42, Transparency 35. Scored as of 2026-08-24.

'Nicotinamide Single Nucleotide' — auto-fail: misleading_naming. The correct name of the NAD+ precursor commonly supplemented is Nicotinamide MONOnucleotide (NMN). 'Single Nucleotide' is either (a) a translation error masking that the product is NMN — in which case honest relabeling as NMN is straightforward, OR (b) a distinct compound that doesn't have the NMN research base — in which case using NMN-adjacent naming is misleading. Either way, the ambiguity conceals what the buyer is actually getting. Small brand (Vivalo, same pattern as previous batches). Held below Standard by naming ambiguity + no per-cap dose disclosure + no sourcing information. Would move to Standard 55+ with corrected labeling (NMN, if that's the actual active) + dose + sourcing.

Strongest: Safety at 60/100 (adverse-event profile, interaction risk, and dose ceiling) and Evidence at 45/100 (quality of published RCT support for the active ingredients at the label dose). Weakest: Formulation at 42/100 (dose adequacy, bioavailability form, and ingredient redundancy) and Transparency at 35/100 (dose disclosure vs proprietary blends, and honesty of marketing claims). All six dimensions feed the overall Vyvata score; a weakness on any one dimension pulls the overall down proportionally.

No third-party certifications (NSF, USP, ConsumerLab, or equivalent) were on record at the time of scoring. This affects the Manufacturing dimension score. The manufacturer may test internally or have obtained certification more recently — check the current product label for the most up-to-date information.

This product triggered the Vyvata auto-fail rule "misleading_naming", which places it in the Rejected tier regardless of its scores on other dimensions. See the full explanation above and the methodology page for the current list of auto-fail rules.

Would move to Standard 55+ with corrected labeling (NMN, if that's the actual active) + dose + sourcing.

The top-ranked longevity & cellular health product in the Vyvata catalog is currently Tru Niagen - Niagen 300 mg Nikotinamid Ribosid Supplement for Anti-Aging & Cellular Energy Support - 30 Capsules at 78/100. See the full ranked list of 131 scored products in this subcategory at https://vyvata.com/pages/best-longevity-and-cellular-health-supplements-ranked.

The Vyvata Scoring Framework rates every listed product 0–100 across six dimensions: Evidence, Formulation, Manufacturing, Safety, Transparency, and Sustainability. Tier bands: Elite 85–100 (top-tier evidence + formulation + manufacturing), Verified 70–84 (strong on most dimensions), Standard 50–69 (solid but with weaknesses called out), Rejected 0–49 (specific failures documented). Rejected products remain listed with reasons. Full methodology at https://vyvata.com/pages/methodology.

The Vyvata score measures product integrity against a published rubric, not customer sentiment. For customer reviews and community discussion, search external platforms directly: Amazon (https://www.amazon.com/s?k=Vivalo%2060%20Capsules%20Nicotinamide%20Single%20Nucleotide%20Capsules),Google(https://www.google.com/search?q=Vivalo%2060%20Capsules%20Nicotinamide%20Single%20Nucleotide%20Capsules+reviews),Reddit(https://www.reddit.com/search/?q=Vivalo%2060%20Capsules%20Nicotinamide%20Single%20Nucleotide%20Capsules%20review),andTrustpilot(https://www.trustpilot.com/search?query=Vivalo%2060%20Capsules%20Nicotinamide%20Single%20Nucleotide%20Capsules).Vyvatadoesnotaggregate,republish,orlicensethosethird-partyreviews.